Successful Treatment of REM Sleep Behavior Disorder With Sodium Oxybate
- 1 May 2009
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Neuropharmacology
- Vol. 32 (3), 158-159
- https://doi.org/10.1097/wnf.0b013e318193e394
Abstract
To identify the effectiveness of sodium oxybate in treating the rapid eye movement sleep behavior disorder (RBD). Report of effectiveness of sodium oxybate in a patient with severe RBD who was unresponsive to all other standard medication. The patient's severe symptoms had persisted unchanged for 5 years despite multiple drug treatments. They responded promptly to low-dose sodium oxybate treatment with video confirmation of cessation of physical activities during sleep. This improvement was maintained during 12 months of follow-up. These novel findings indicate that sodium oxybate should be considered in RBD when other treatments are ineffective or poorly tolerated. They also suggest that RBD and cataplexy may in part share a common pathophysiology.Keywords
This publication has 3 references indexed in Scilit:
- Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patientsSleep Medicine, 2005
- Brainstem in Multiple System Atrophy: Clinicopathological CorrelationsCellular and Molecular Neurobiology, 2003
- REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literatureJournal of Sleep Research, 1993